Cognetivity Enters Distribution Arrangement For Dementia Product In Middle East

Cognetivity Neurosciences (CSE: CGN) is expanding its global distribution. The firm this morning announced it has signed a distribution agreement for its medical device product in the Middle East region.

The arrangement will see Emitac Healthcare Solutions become an official distributor of the firms CognICA product. The firm is reportedly a leading provider in the region, having operated in the Middle East for four and a half decades. The firm has major relationships that include Philips Healthcare, Samsung Ultrasound Systems, and the UAE’s Ministry of Health & Prevention.

The arrangement was announced this morning in connection with Arab Health 2022, the largest medical equipment exhibition in the region. The timing is significant, following a recently published study highlighting that the Middle East, particularly the UAE and other gulf nations, are expected to undergo the highest increase globally of people living with dementia by 2050.

Antimony Resources — sponsored Sponsored · Antimony Resources

The rollout to the region follows the deployment of the device with the United Kingdom’s National Health Service, as well as the Clemenceau Medical Center in Dubai, among other regions.

“We’re delighted to have established this partnership with Emitac Healthcare Solutions. As its list of existing customers and clients shows, Emitac is a hugely-respected name in the region, bringing the experience and the manpower required to service our clientele and reassure customers of our commitment in this market,” commented Dr Sina Habibi, CEO of the company on the development.

Cognetivity Neurosciences last traded at $0.50 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Trending

Related News

Cognetivity Neurosciences Sees Scientific Paper Outline Strong Use-Case For Integrated Cognitive Assessment Test

Cognetivity Neurosciences (CSE: CGN) this morning announced that it has seen another publication of a...

Wednesday, July 7, 2021, 09:31:46 AM

Cognetivity Neurosciences Sees Granting Of FDA Clearance For Cognitive Assessment Tool

Cognetivity Neurosciences (CSE: CGN) has reached a major achievement. The company has been granted FDA...

Wednesday, October 20, 2021, 09:22:23 AM

Cognetivity’s Brain Health Monitoring App – The Daily Dive

On this Daily Dive episode, Cassandra talks to Dr. Sina Habibi, CEO of Cognetivity Neurosciences...

Friday, November 19, 2021, 03:28:00 PM

Cognetivity Sees Its Cognitive Tool Used In Clinical Study For OCD

While it may have been initially developed for the early detection of Alzheimer’s disease or...

Tuesday, September 13, 2022, 08:38:28 AM

Cognetivity: Utilizing AI for Early Alzheimer’s Intervention

Sina Habibi, Co-founder & CEO of Cognetivity Neurosciences (CSE: CGN) sits down with us today...

Wednesday, June 14, 2023, 01:30:00 PM